Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
vApGFh7gSfPXtmjy